Interest of targeting either cortical area Brodmann 9 or 46 in rTMS treatment for depression: A preliminary randomized study

Clinical Neurophysiology

Volumn 125, Issue 12, 2014, Pages 2384-2389

  Trojak, Benoit ^a,b   Meille, Vincent ^a   Jonval, Lysiane ^a   Schuffenecker, Nicolas ^a   Haffen, Emmanuel ^c   Schwan, Raymund ^d,e   Bonin, Bernard ^a,b   Chauvet Gelinier, Jean Christophe ^a,b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e Department of Psychiatry   (France)

Author keywords

Brodmann; Cortical target; Depression; Dorsolateral prefrontal cortex; rTMS

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; BRODMANN AREA 46; BRODMANN AREA 9; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAMILTON DEPRESSION RATING SCALE; HEADACHE; HUMAN; IMAGING SOFTWARE; MALE; MENTAL PATIENT; MIDDLE AGED; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PREFRONTAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RANDOMIZED CONTROLLED TRIAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; TIC; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; AGED; BRAIN CORTEX; BRAIN MAPPING; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; PROCEDURES; PSYCHOLOGY;

ADULT; AGED; BRAIN MAPPING; CEREBRAL CORTEX; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84927689163     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2014.04.001     Document Type: Article

References (27)

1. American Psychiatric Association Diagnostic and Statistical Manual of mental disorders (DSM-IV), text revision 2000, American Psychiatric Association, Washington, DC.
2. Barker A.T., Jalinous R., Freeston I.L. Noninvasive magnetic stimulation of the human motor cortex. Lancet 1985, 1:1106-1107.
3. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
4. Dell'osso B., Camuri G., Castellano F., Vecchi V., Benedetti M., Bortolussi S., et al. Meta-review of metanalytic studies with repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of major depression. Clin Pract Epidemiol Ment Health 2011, 7:167-177.
5. Fitzgerald P.B., Brown T.L., Marston N.A., Daskalakis Z.J., De Castella A., Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 2003, 60:1002-1008.
6. Fitzgerald P.B., Hoy K., McQueen S., Maller J.J., Herring S., Segrave R., et al. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 2009, 34:1255-1262.
7. Fox M.D., Buckner R.L., White M.P., Greicius M.D., Pascual-Leone A. Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. Biol Psychiatry 2012, 1(72):595-603.
8. George M.S., Lisanby S.H., Avery D., McDonald W.M., Durkalski V., Pavlicova M., et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a Sham-controlled randomized trial. Arch Gen Psychiatry 2010, 67:507-516.
9. George M.S., Post R.M. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry 2011, 168:356-364.
10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
11. Herbsman T., Avery D., Ramsey D., Holtzheimer P., Wadjik C., Hardaway F., et al. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 2009, 66:509-515.
12. Herwig U., Padberg F., Unger J., Spitzer M., Schönfeldt-Lecuona C. Transcranial Magnetic Stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol Psychiatry 2001, 50:58-61.
13. Jansen J.M., Daams J.G., Koeter M.W., Veltman D.J., van den Brink W., Goudriaan A.E. Effects of non-invasive neurostimulation on craving: a meta-analysis. Neurosci Biobehav Rev 2013, 37:2472-2480.
14. Johnson K.A., Baig M., Ramsey D., Lisanby S.H., Avery D., McDonald W.M., et al. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul 2013, 6:108-117.
15. Kauffmann C.D., Cheema M.A., Miller B.E. Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depress Anxiety 2004, 19:59-62.
16. Klein E., Kreinin I., Chistyakov A., Koren D., Mecz L., Marmur S., et al. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 1999, 56:315-320.
17. Lam R.W., Chan P., Wilkins-Ho M., Yatham L.Y. Repetitive Transcranial Magnetic Stimulation for the treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 2008, 53:621-631.
18. Lingjærde O., Ahlfors U.G., Bech P., Dencker S., Elgen K. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987, 76:1-100.
19. Loo C.K., Mitchell P.B. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 2005, 88:255-267.
20. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
21. O'Reardon J.P., Solvason H.B., Janicak P.G., Sampson S., Isenberg K.E., Nahas Z., et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment. Biol Psychiatry 2007, 62:1208-1216.
22. Pridmore S., Fernandes Filho J.A., Nahas Z., Liberatos C., George M.S. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualisation movement method. J ECT 1998, 14:25-27.
23. Rorden C., Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000, 12:191-200.
24. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. The Safety of TMS Consensus group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120:2008-2039.
25. Stern W.M., Tormos J.M., Press D.Z., Pearlman C., Pascual-Leone A. Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. J Neuropsychiatry Clin Neurosci 2007, 19:179-186.
26. Thase M.E., Rush A.J. Treatment resistant depression. Psychopharmacology: the fourth generation of progress 1995, 1081-1097. Raven Press, New York. F.E. Bloom, D.F. Kupfer (Eds.).
27. Zilles K., Amnunts K. Centenary of Brodmann's map - conception and fate. Nat Rev Neurosci 2010, 11:139-145.